The National Times - EU eyes migration clampdown with push on deportations, visas

EU eyes migration clampdown with push on deportations, visas


EU eyes migration clampdown with push on deportations, visas
EU eyes migration clampdown with push on deportations, visas / Photo: © AFP/File

The European Union on Thursday laid out plans to overhaul its visa system and step up deportations as part of a five-year migration strategy that cements a hardening line on the hot-button issue.

Change text size:

Irregular arrivals in the 27-nation bloc were down by more than a quarter in 2025, according to the EU's border agency -- but political pressure to act remains high.

"The priority is clear: bringing illegal arrival numbers down and keeping them down," Magnus Brunner, the EU's commissioner for migration, said.

The strategy unveiled Thursday stressed the need to boost deportations of failed asylum-seekers among the bloc's priorities.

"Abuse gives migration a bad name -- it undermines public trust and ultimately takes away from our ability to provide protection and undercuts our drive to attract talent," said Brunner.

The European Parliament is currently examining a legal text put forward by the European Commission allowing for so-called "return hubs" to be set up outside the EU's borders.

Criticised by rights groups, the proposal also envisages harsher penalties for migrants who refuse to leave European territory, including longer periods of detention.

European governments are under pressure to take a tougher stance amid a souring of public opinion on migration that has fuelled a rightward shift across the bloc.

- 'Flawed' approach -

The strategy also mentioned reinforcing an "assertive migration diplomacy" to persuade third countries to help stop migrants from reaching Europe and take back their nationals with no right to stay.

Brussels recently struck or is negotiating deals with Northern African countries including Tunisia, Mauritania, Egypt and Morocco, whereby it gets help controlling migration flows in return for aid and investments.

Amnesty International criticised the EU's approach as "flawed".

It "only heightens its dependence on third countries to manage migration, while making it complicit in any rights violations that may result", said Olivia Sundberg Diez, a policy analyst with the human rights group.

Brussels also put forward a brand-new visa strategy, with the stated objective of using the granting of access to EU territory to certain nationals as a diplomatic means to foster its policy goals.

It's "one of the strongest tools in our hands", said a commission source.

In particular, the EU wants to sanction countries that refuse to take back their nationals by restricting the issuance of visas, while easing procedures to attract skilled workers.

The commission is expected to present a plan for reform by the end of the year.

T.Bailey--TNT

Featured

Carney touts Canada 'pivot' away from US as Trump levels new threat

Canadian Prime Minister Mark Carney said Tuesday that reducing economic ties with the United States would come at a cost but the benefits were clear, as President Donald Trump threatened new penalties targeting Canada.

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Change text size: